Dr. Blaylock Reports: Immunoexcitotoxicity; Case Example; Anatomy & Biochemistry; Anti-oxidant system; Microglial Activation; Summary

  • Rate This

SUMMARY:  The Major molecular disease process underlying many diseases in the 21st Century is Immuno-Excitotoxicity, the body's normal response to cellular injury and its over-reaction that leads to many disease states.   Aneurysm formation, SAH, Dementia, Parkinson, Alzheimer's, Autism Spectrum Disorders,  Allergic encehpalopathy, ALS, Diabetes, Atherosclerosis, and even osteoarthritis, spinal cord injury  all have immunocompromised excitotoxicity  as a fundamental biochemical and molecular process.  Repeated Chronic Injures to the CNS and other systems will lead to activation of the microglia and immune system with resulting excitotoxicity that  destroys cells. With 40 trillion cells in the body and each having thousands or millions of chemical reactions 24/7/365,   the generation of Free Radicals from chemical reactions sets off an immune excitotoxic response that is damaging. This changes can be muted by the body's anti-oxidant system plus the external  supplementation by a series of antioxidants, flavonoids, & minerals necessary to participate in this widespread metabolic symphony. Most people are deficient in basic chemicals to support this widespread  metabolic activity.  from dietary changes and external toxins in our environment. Which system prevails in this war between the pro-inflammatory and anti- inflammatory metabolic reactions will determine the outcome of various diseases. These events lead to a. chronic disease state and aging.  This 5 part program is presented in its entirely of 90 minutes or in three 30 minute parts. (A,B,C)   A, Part 1. Case example; 2. Basic Anatomy and Biochemistry of Immuno-excitotoxicity; B,  3, The Anti-oxidant system, and specific Antioxidants;  C, 4-Microglial activation;  and 5, Summary and influence of the Pharmaceutical industry to control Supplements , like antioxidants.  (JIA) PRINT

Speaker
  • James I. Ausman, MD, MA, PhD

    CEO SNI and SNI Digital; Emeritus Professor Neurosurgery

  • Russell Blaylock, MD

    CEO, Theoretical Neuroscience Research